Strata Critical Medical, Inc. 8-K

What Happened Strata Critical Medical, Inc. announced its financial results for the quarter and year ended December 31, 2025 by issuing a press release on March 3, 2026. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8-K (Item 2.02, Results of Operations and Financial Condition). The 8-K was signed by William A. Heyburn, Co‑Chief Executive Officer and Chief Financial Officer.

Key Details

• Press release dated March 3, 2026 reporting quarterly results for the period ended December 31, 2025 (Exhibit 99.1).
• Form 8-K filed under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Exhibits).
• The report was furnished (not “filed”) with the SEC and was signed by William A. Heyburn (Co‑CEO & CFO).
• An Interactive XBRL cover page (Exhibit 104) was included with the filing.

Why It Matters This 8-K notifies investors that Strata has publicly released its Q4/2025 earnings and related financial information. Retail investors should review the press release (Exhibit 99.1) to see revenue, profit/loss, and any commentary on guidance or trends; the press release is the primary source for near‑term earnings and revenue figures. For full audited figures and more detailed financial statements, watch for the company’s upcoming periodic filings (Form 10‑Q/10‑K) and investor presentations that may follow the press release.